NAZISH EKRAM: Open Payments
NPI 1346496965 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,935 in 124 payments from 13 companies in 2025. Trend: 2023 $2,446 · 2024 $4,003 · 2025 $6,935
Consulting: $4,350Food & beverage: $2,445Travel & lodging: $140
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $4,525 |
| ABBVIE INC. | 26 | $619 |
| Lilly USA, LLC | 19 | $505 |
| Novo Nordisk Inc | 17 | $376 |
| Axsome Therapeutics, Inc. | 11 | $242 |
| Currax Pharmaceuticals LLC | 24 | $183 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $128 |
| AstraZeneca Pharmaceuticals LP | 7 | $122 |
| Aimmune Therapeutics, Inc. | 5 | $104 |
| Dexcom, Inc. | 2 | $48 |
Products named: JARDIANCE, VRAYLAR, Sunosi, Wegovy, QULIPTA, MOUNJARO, ONZETRA XSAIL, Kerendia.
Industry payments across IL — which companies pay providers there.
